To generate early drug-tolerant cells, PC9 and/or SKMEL28 cells were plated on 100 mm plates (1 × 105 cells/plate) and allowed to attach for 16 h. Media were replaced with fresh growth media containing gefitinib (Selleck Chemicals, Houston, TX, USA) (5 μM) or dabrafenib (Selleck Chemicals) (5 μM) for PC9 or SKMEL28 cells, respectively. Cells were cultured for the indicated amount of time, and media changes were performed every 2–3 days.
Pc9 cells
PC9 cells are a type of lung cancer cell line that are widely used in cancer research. They are derived from human lung adenocarcinoma tissue and exhibit characteristics of non-small cell lung cancer. PC9 cells are commonly utilized in various in vitro studies, including drug screening, cell biology, and molecular biology experiments.
Lab products found in correlation
9 protocols using pc9 cells
Generation of Drug-Tolerant Cancer Cells
To generate early drug-tolerant cells, PC9 and/or SKMEL28 cells were plated on 100 mm plates (1 × 105 cells/plate) and allowed to attach for 16 h. Media were replaced with fresh growth media containing gefitinib (Selleck Chemicals, Houston, TX, USA) (5 μM) or dabrafenib (Selleck Chemicals) (5 μM) for PC9 or SKMEL28 cells, respectively. Cells were cultured for the indicated amount of time, and media changes were performed every 2–3 days.
Cell Line Acquisition and Authentication
Cell Culture Protocols for Cancer and Normal Cell Lines
Cell Culture Protocols for Various Cells
Culturing Diverse Cell Lines for EGFR Research
Fluorescent Lung Cancer Cell Lines
Cell culture conditions for cancer cell lines
Cell Culture Conditions for Cancer Research
Establishment and Characterization of Isogenic EGFR-Resistant Cell Lines
Resulting resistant and sensitive subclones underwent lentiviral transduction with plasmid vectors encoding EGFP and mCherry fluorescent proteins with attached nuclear localization sequence (plasmids were a gift from A.M.’s laboratory at Moffitt Cancer Center). Derivative cell lines with heritable fluorescent protein expression were selected in puromycin (MP Biomedical, 100552).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!